Protease Inhibitors Produced byStreptomyces libani
نویسندگان
چکیده
منابع مشابه
SESQUITERPENOIDS AS AVIAN MYELOBLASTOSIS VIRUS PROTEASE INHIBITORS PRODUCED BYStachybotrys sp
Aspartic retroviral proteases play an important role in the processing of viral polyproteins into mature functional proteins1}. An inhibitor of avian myeloblastosis virus protease (AMV-protease) could be a possible candidate for antiviral-therapy and could be used, for example, as an anti-HIV agent2). In the course of screening for AMV-protease inhibitors, we discovered Mer-NF5003B, E and F, no...
متن کاملScreening Efficacy of Available HIV Protease Inhibitors on COVID-19 Protease
Background and Aim: Advent of COVID-19 attracted the attentions of researchers to develop drugs for its treatment. Besides efforts on developing new drugs, screening available drugs for efficacy on COVID-19 could be an urgent action of initiating its pharmacotherapy. In this study, efficacy of HIV protease inhibitors on COVID-19 protease has been examined. Methods: Molecular docking based scree...
متن کاملProtease Inhibitors: Emphasizing Functional Aspects of Aspartic Protease Inhibitors
Aspartic proteases are relatively a small group of proteolytic enzymes. Over the last decade, they have received tremendous research interest as potential targets for pharmaceutical intervention as many have been shown to play significant roles in physiological and pathological processes. Despite numerous efforts, however, the only inhibitors for aspartic proteases currently in the market are d...
متن کاملMicrobial Aspartic protease inhibitors
Aspartic proteases are relatively a small group of proteolytic enzymes. Over the last decade, they have received tremendous research interest as potential targets for pharmaceutical intervention as many have been shown to play significant roles in physiological and pathological processes. Despite numerous efforts, however, the only inhibitors for aspartic proteases currently in the market are d...
متن کاملHIV-1 protease inhibitors.
Treatment of human immunodeficiency virus type 1 (HIV-1) infection with regimens that include protease inhibitors (PIs) has contributed to marked improvements in HIV-related disease progression and mortality. Five PIs are approved by the US Food and Drug Administration and have potent activity in vitro. PIs with 2 nucleoside analogue reverse transcriptase inhibitors have demonstrated prolonged ...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Agricultural and Biological Chemistry
سال: 1979
ISSN: 0002-1369
DOI: 10.1080/00021369.1979.10863534